Low skeletal muscle mass has been suggested as a risk factor for NAFLD, considering the important role of skeletal muscles in insulin-mediated glucose disposal and secretion of myokines14,15. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.